SimpactCyan 1.0: An Open-source Simulator for Individual-Based Models in HIV Epidemiology with R and Python Interfaces.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
17 12 2019
Historique:
received: 31 10 2018
accepted: 29 11 2019
entrez: 19 12 2019
pubmed: 19 12 2019
medline: 6 11 2020
Statut: epublish

Résumé

SimpactCyan is an open-source simulator for individual-based models in HIV epidemiology. Its core algorithm is written in C++ for computational efficiency, while the R and Python interfaces aim to make the tool accessible to the fast-growing community of R and Python users. Transmission, treatment and prevention of HIV infections in dynamic sexual networks are simulated by discrete events. A generic "intervention" event allows model parameters to be changed over time, and can be used to model medical and behavioural HIV prevention programmes. First, we describe a more efficient variant of the modified Next Reaction Method that drives our continuous-time simulator. Next, we outline key built-in features and assumptions of individual-based models formulated in SimpactCyan, and provide code snippets for how to formulate, execute and analyse models in SimpactCyan through its R and Python interfaces. Lastly, we give two examples of applications in HIV epidemiology: the first demonstrates how the software can be used to estimate the impact of progressive changes to the eligibility criteria for HIV treatment on HIV incidence. The second example illustrates the use of SimpactCyan as a data-generating tool for assessing the performance of a phylodynamic inference framework.

Identifiants

pubmed: 31848434
doi: 10.1038/s41598-019-55689-4
pii: 10.1038/s41598-019-55689-4
pmc: PMC6917719
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

19289

Références

Nat Chem. 2011 Sep 23;3(10):745-8
pubmed: 21941234
Nat Methods. 2012 Jul 30;9(8):772
pubmed: 22847109
AIDS Res Hum Retroviruses. 2014 Dec;30(12):1226-35
pubmed: 25275430
J Int AIDS Soc. 2013 Apr 24;16:18034
pubmed: 23618365
Bioinformatics. 2019 Jun 1;35(11):1852-1861
pubmed: 30395173
J Infect Dis. 2008 Sep 1;198(5):687-93
pubmed: 18662132
Sci Rep. 2017 Nov 23;7(1):16117
pubmed: 29170407
Lancet HIV. 2017 Jan;4(1):e41-e50
pubmed: 27914874
J Stat Softw. 2018 Apr;84:
pubmed: 29731699
Lancet HIV. 2017 Feb;4(2):e83-e92
pubmed: 27863998
PLoS One. 2016 Feb 10;11(2):e0148459
pubmed: 26863322
Proc Natl Acad Sci U S A. 1999 Sep 28;96(20):11549-53
pubmed: 10500214
Science. 2014 Mar 21;343(6177):1243727
pubmed: 24653038
J Int AIDS Soc. 2011 Sep 13;14:44
pubmed: 21914208
Virus Evol. 2017 Oct 20;3(2):vex029
pubmed: 29942652
J AIDS Clin Res. 2016 Feb;7(2):
pubmed: 27148468
Med Decis Making. 2017 Feb;37(2):224-233
pubmed: 27646567
BMC Infect Dis. 2017 Sep 11;17(1):612
pubmed: 28893198
Retrovirology. 2013 May 02;10:49
pubmed: 23639104
PLoS One. 2014 May 27;9(5):e98272
pubmed: 24867402
AIDS. 2016 Aug 24;30(13):2009-20
pubmed: 27314176
Mol Biol Evol. 2017 Jan;34(1):185-203
pubmed: 28053012
PLoS Comput Biol. 2014 Apr 17;10(4):e1003570
pubmed: 24743590
J Chem Phys. 2007 Dec 7;127(21):214107
pubmed: 18067349
PLoS One. 2012;7(11):e49661
pubmed: 23166743
Trials. 2017 Aug 18;18(1):383
pubmed: 28821264
Pathog Dis. 2018 Jul 1;76(5):
pubmed: 29986020
Bioinformatics. 2011 Feb 15;27(4):592-3
pubmed: 21169378
Comput Appl Biosci. 1997 Jun;13(3):235-8
pubmed: 9183526
Am J Reprod Immunol. 2013 Feb;69 Suppl 1:74-9
pubmed: 23157424
PLoS Med. 2008 Mar 18;5(3):e50
pubmed: 18351795
Proc Natl Acad Sci U S A. 2007 Oct 30;104(44):17441-6
pubmed: 17954909
Mol Biol Evol. 2014 Jan;31(1):6-17
pubmed: 24085839

Auteurs

Jori Liesenborgs (J)

Expertise Centre for Digital Media, Hasselt University - tUL, Diepenbeek, Belgium.

Diana M Hendrickx (DM)

Center for Statistics, I-BioStat, Hasselt University, Diepenbeek, Belgium.

Elise Kuylen (E)

IDLab, University of Antwerp, Antwerp, Belgium.
Centre for Health Economics Research and Modelling Infectious Diseases and Centre for the Evaluation of Vaccination, Vaccine & Infectious Disease Institute, University of Antwerp, Antwerp, Belgium.

David Niyukuri (D)

The South African Department of Science and Technology-National Research Foundation (DST-NRF) Centre of Excellence in Epidemiological Modelling and Analysis (SACEMA), Stellenbosch University, Stellenbosch, South Africa.
Department of Global Health, Faculty of Medicine and Health, Stellenbosch University, Stellenbosch, South Africa.

Niel Hens (N)

Center for Statistics, I-BioStat, Hasselt University, Diepenbeek, Belgium.
Centre for Health Economics Research and Modelling Infectious Diseases and Centre for the Evaluation of Vaccination, Vaccine & Infectious Disease Institute, University of Antwerp, Antwerp, Belgium.

Wim Delva (W)

Center for Statistics, I-BioStat, Hasselt University, Diepenbeek, Belgium. wimdelva@gmail.com.
The South African Department of Science and Technology-National Research Foundation (DST-NRF) Centre of Excellence in Epidemiological Modelling and Analysis (SACEMA), Stellenbosch University, Stellenbosch, South Africa. wimdelva@gmail.com.
Department of Global Health, Faculty of Medicine and Health, Stellenbosch University, Stellenbosch, South Africa. wimdelva@gmail.com.
International Centre for Reproductive Health, Ghent University, Ghent, Belgium. wimdelva@gmail.com.
Rega Institute for Medical Research, KU Leuven, Leuven, Belgium. wimdelva@gmail.com.
School for Data Science and Computational Thinking, Stellenbosch University, Stellenbosch, South Africa. wimdelva@gmail.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH